Work

Abstract 3166: TKI adaptive resistance in HER2-driven non-small cell lung cancer at minimal residual disease stage can be targeted using cell surface-directed therapies

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-3166

Authors: Manale El Kharbili, Daniel Wilkinson, Lauren Giesy, Sharon R. Pine, Peter Fecci, Kyle Concannon

Institution: University of Colorado Anschutz

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148847309

Cites:

Cited by:

Related to: